| 1 | 9152599 | Inhibition of human drug metabolizing cytochromes P450 by anastrozole, a potent and selective inhibitor of aromatase. | Drug Metab Dispos | 1997 May |
3 |
| 2 | 9394367 | Anastrozole: a new selective nonsteroidal aromatase inhibitor. | Oncology (Williston Park) | 1997 Nov |
3 |
| 3 | 9619713 | Clinical efficacy of the aromatase inhibitor anastrozole in relation to prolactin secretion in heavily pretreated metastatic breast cancer. | Tumori | 1998 Jan-Feb |
2 |
| 4 | 10623624 | Synthesis and biochemical evaluation of novel inhibitors of aromatase (AR) using an enhanced representation of the active site of AR derived from the consideration of the reaction mechanism. | Biochem Biophys Res Commun | 2000 Jan 7 |
1 |
| 5 | 10732791 | Use of aromatase inhibitors in breast carcinoma. | Endocr Relat Cancer | 1999 Mar |
1 |
| 6 | 10999781 | Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback. | J Clin Endocrinol Metab | 2000 Sep |
1 |
| 7 | 11078488 | Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial. Arimidex Study Group. | J Clin Oncol | 2000 Nov 15 |
2 |
| 8 | 11096352 | Gonadotropins stimulate growth of MCF-7 human breast cancer cells by promoting intracellular conversion of adrenal androgens to estrogens. | Oncology | 2000 |
1 |
| 9 | 11329794 | [Development of a novel aromatase inhibitor, anastrozole (Arimidex)--its basic and clinical studies]. | Gan To Kagaku Ryoho | 2001 Apr |
4 |
| 10 | 11350888 | Influence of neoadjuvant anastrozole (Arimidex) on intratumoral estrogen levels and proliferation markers in patients with locally advanced breast cancer. | Clin Cancer Res | 2001 May |
1 |
| 11 | 11384878 | Intracellular aromatase and its relevance to the pharmacological efficacy of aromatase inhibitors. | J Steroid Biochem Mol Biol | 2001 Jan-Mar |
1 |
| 12 | 11550075 | Aromatase, aromatase inhibitors, and breast cancer. | Am J Ther | 2001 Sep-Oct |
1 |
| 13 | 11745278 | Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma. | Cancer | 2001 Nov 1 |
1 |
| 14 | 11821457 | Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study. | J Clin Oncol | 2002 Feb 1 |
3 |
| 15 | 11850213 | Biological and clinical effects of aromatase inhibitors in neoadjuvant therapy. | J Steroid Biochem Mol Biol | 2001 Dec |
2 |
| 16 | 11904449 | Testosterone attenuates expression of vascular cell adhesion molecule-1 by conversion to estradiol by aromatase in endothelial cells: implications in atherosclerosis. | Proc Natl Acad Sci U S A | 2002 Mar 19 |
5 |
| 17 | 11916226 | Are differences in the available aromatase inhibitors and inactivators significant? | Clin Cancer Res | 2001 Dec |
1 |
| 18 | 11916231 | Preliminary data from ongoing adjuvant aromatase inhibitor trials. | Clin Cancer Res | 2001 Dec |
1 |
| 19 | 11983488 | Short-term effects of anastrozole treatment on insulin-like growth factor system in postmenopausal advanced breast cancer patients. | J Steroid Biochem Mol Biol | 2002 Apr |
2 |
| 20 | 12113240 | Aromatase inhibitors in breast cancer therapy. | Expert Rev Anticancer Ther | 2002 Apr |
1 |
| 21 | 12177804 | Effect of neoadjuvant treatment with anastrozole on tumour histology in postmenopausal women with large operable breast cancer. | Br J Cancer | 2002 Jul 29 |
1 |
| 22 | 12186625 | Anastrozole in the management of breast cancer. | Expert Opin Pharmacother | 2002 Sep |
1 |
| 23 | 12364416 | The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma. | J Clin Endocrinol Metab | 2002 Oct |
1 |
| 24 | 12402060 | The evolving role of aromatase inhibitors in breast cancer. | Int J Clin Oncol | 2002 Oct |
5 |
| 25 | 12421108 | Anastrozole: in early breast cancer. | Drugs | 2002 |
1 |
| 26 | 12713499 | Treatment of breast cancer in countries with limited resources. | Breast J | 2003 May-Jun |
4 |
| 27 | 12722879 | Aromatase inhibitors for treatment of postmenopausal patients with breast cancer. | Expert Rev Anticancer Ther | 2003 Apr |
2 |
| 28 | 12727558 | The effect of high dehydroepiandrosterone sulfate levels on tamoxifen blockade and breast cancer progression. | Am J Surg | 2003 May |
1 |
| 29 | 12843139 | Familial hyperestrogenism in both sexes: clinical, hormonal, and molecular studies of two siblings. | J Clin Endocrinol Metab | 2003 Jul |
1 |
| 30 | 12875605 | The current status of aromatase inhibitors in the management of breast cancer. | Surg Clin North Am | 2003 Aug |
1 |
| 31 | 12938779 | Aromatase inhibition for the treatment of idiopathic hypogonadotropic hypogonadism in men with premature ejaculation. | South Med J | 2003 Jun |
2 |
| 32 | 14513436 | Aromatase inhibitors in early breast cancer treatment. | Semin Oncol | 2003 Aug |
1 |
| 33 | 14535533 | Future directions in the endocrine therapy of breast cancer. | Breast Cancer Res Treat | 2003 |
1 |
| 34 | 14584060 | Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses. | Cancer | 2003 Nov 1 |
1 |
| 35 | 14623524 | Neoadjuvant tamoxifen and aromatase inhibitors: comparisons and clinical outcomes. | J Steroid Biochem Mol Biol | 2003 Sep |
1 |
| 36 | 14623537 | 'Arimidex' (anastrozole) versus tamoxifen as adjuvant therapy in postmenopausal women with early breast cancer--efficacy overview. | J Steroid Biochem Mol Biol | 2003 Sep |
2 |
| 37 | 14623539 | An integrated view of aromatase and its inhibition. | J Steroid Biochem Mol Biol | 2003 Sep |
1 |
| 38 | 14687437 | Focus on anastrozole and breast cancer. | Curr Med Res Opin | 2003 |
2 |
| 39 | 14693319 | Cost-effectiveness of anastrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer. | Clin Ther | 2003 Nov |
1 |
| 40 | 14703069 | A review of the efficacy of anastrozole in postmenopausal women with advanced breast cancer with visceral metastases. | Breast Cancer Res Treat | 2003 Dec |
2 |
| 41 | 14734491 | Data from the Arimidex, tamoxifen, alone or in combination (ATAC) trial: implications for use of aromatase inhibitors in 2003. | Clin Cancer Res | 2004 Jan 1 |
4 |
| 42 | 15083379 | Aromatase inhibitors: new endocrine treatment of breast cancer. | Semin Reprod Med | 2004 Feb |
1 |
| 43 | 15109437 | Effect of estrogen deprivation on follicle/oocyte maturation and embryo development in mice. | Chin Med J (Engl) | 2004 Apr |
1 |
| 44 | 15125747 | The impact of hormone receptor status on the clinical efficacy of the new-generation aromatase inhibitors: a review of data from first-line metastatic disease trials in postmenopausal women. | Breast J | 2004 May-Jun |
1 |
| 45 | 15150604 | Aromatase inhibition in the treatment of advanced breast cancer: is there a relationship between potency and clinical efficacy? | Br J Cancer | 2004 May 4 |
2 |
| 46 | 15305403 | Breast surgery in the 'Arimidex, Tamoxifen Alone or in Combination' (ATAC) trial: American women are more likely than women from the United Kingdom to undergo mastectomy. | Cancer | 2004 Aug 15 |
1 |
| 47 | 15358790 | Biochemical and biological characterization of a novel anti-aromatase coumarin derivative. | J Biol Chem | 2004 Nov 12 |
1 |
| 48 | 15368322 | Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer. | Cancer | 2004 Sep 15 |
1 |
| 49 | 15378476 | The role of aromatase inhibitors in the adjuvant treatment of breast carcinoma: the M. D. Anderson Cancer Center evidence-based approach. | Cancer | 2004 Oct 1 |
1 |
| 50 | 15380230 | Synthesis and evaluation of 4-triazolylflavans as new aromatase inhibitors. | Bioorg Med Chem Lett | 2004 Oct 18 |
1 |